Medical - Healthcare Plans
Compare Stocks
2 / 10Stock Comparison
CI vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
CI vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $72.68B | $330.28B |
| Revenue (TTM) | $277.94B | $449.71B |
| Net Income (TTM) | $6.29B | $12.04B |
| Gross Margin | 9.3% | 18.8% |
| Operating Margin | 3.4% | 4.2% |
| Forward P/E | 9.1x | 19.9x |
| Total Debt | $31.46B | $78.39B |
| Cash & Equiv. | $7.68B | $24.36B |
CI vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cigna Corporation (CI) | 100 | 139.7 | +39.7% |
| UnitedHealth Group … (UNH) | 100 | 119.4 | +19.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CI vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CI is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 11.3%, EPS growth 82.9%, 3Y rev CAGR 15.1%
- Lower volatility, beta 0.35, Low D/E 75.1%, current ratio 0.85x
- Beta 0.35, yield 2.2%, current ratio 0.85x
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 217.0% 10Y total return vs CI's 124.1%
- 11.8% revenue growth vs CI's 11.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.8% revenue growth vs CI's 11.3% | |
| Value | Lower P/E (9.1x vs 19.9x) | |
| Quality / Margins | Combined ratio 1.0 vs CI's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.35 vs UNH's 0.59, lower leverage | |
| Dividends | 2.4% yield, 25-year raise streak, vs CI's 2.2% | |
| Momentum (1Y) | -7.9% vs CI's -15.4% | |
| Efficiency (ROA) | 4.1% ROA vs UNH's 3.9%, ROIC 10.4% vs 9.2% |
CI vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CI vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 1.6x CI's $277.9B. Profitability is closely matched — net margins range from 2.7% (UNH) to 2.3% (CI).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $277.9B | $449.7B |
| EBITDAEarnings before interest/tax | $12.1B | $23.2B |
| Net IncomeAfter-tax profit | $6.3B | $12.0B |
| Free Cash FlowCash after capex | $7.7B | $19.7B |
| Gross MarginGross profit ÷ Revenue | +9.3% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +3.4% | +4.2% |
| Net MarginNet income ÷ Revenue | +2.3% | +2.7% |
| FCF MarginFCF ÷ Revenue | +2.8% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.6% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +29.1% | +0.7% |
Valuation Metrics
CI leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, CI trades at a 55% valuation discount to UNH's 27.5x P/E. On an enterprise value basis, CI's 8.2x EV/EBITDA is more attractive than UNH's 16.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $72.7B | $330.3B |
| Enterprise ValueMkt cap + debt − cash | $96.5B | $384.3B |
| Trailing P/EPrice ÷ TTM EPS | 12.43x | 27.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.09x | 19.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.20x | 16.48x |
| Price / SalesMarket cap ÷ Revenue | 0.26x | 0.74x |
| Price / BookPrice ÷ Book value/share | 1.75x | 3.26x |
| Price / FCFMarket cap ÷ FCF | 8.66x | 20.55x |
Profitability & Efficiency
CI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CI delivers a 15.1% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $12 for UNH. CI carries lower financial leverage with a 0.75x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), CI scores 8/9 vs UNH's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +15.1% | +11.5% |
| ROA (TTM)Return on assets | +4.1% | +3.9% |
| ROICReturn on invested capital | +10.4% | +9.2% |
| ROCEReturn on capital employed | +9.2% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.75x | 0.77x |
| Net DebtTotal debt minus cash | $23.8B | $54.0B |
| Cash & Equiv.Liquid assets | $7.7B | $24.4B |
| Total DebtShort + long-term debt | $31.5B | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 6.77x | 4.71x |
Total Returns (Dividends Reinvested)
Evenly matched — CI and UNH each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CI five years ago would be worth $11,658 today (with dividends reinvested), compared to $9,722 for UNH. Over the past 12 months, UNH leads with a -7.9% total return vs CI's -15.4%. The 3-year compound annual growth rate (CAGR) favors CI at 3.9% vs UNH's -7.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.7% | +8.8% |
| 1-Year ReturnPast 12 months | -15.4% | -7.9% |
| 3-Year ReturnCumulative with dividends | +12.2% | -21.4% |
| 5-Year ReturnCumulative with dividends | +16.6% | -2.8% |
| 10-Year ReturnCumulative with dividends | +124.1% | +217.0% |
| CAGR (3Y)Annualised 3-year return | +3.9% | -7.7% |
Risk & Volatility
Evenly matched — CI and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
CI is the less volatile stock with a 0.35 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs CI's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.35x | 0.59x |
| 52-Week HighHighest price in past year | $338.89 | $409.70 |
| 52-Week LowLowest price in past year | $239.51 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +81.3% | +88.8% |
| RSI (14)Momentum oscillator 0–100 | 51.2 | 83.3 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 8.1M |
Analyst Outlook
UNH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CI as "Buy" and UNH as "Buy". Consensus price targets imply 19.0% upside for CI (target: $328) vs 5.9% for UNH (target: $385). For income investors, UNH offers the higher dividend yield at 2.39% vs CI's 2.20%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $328.00 | $385.43 |
| # AnalystsCovering analysts | 39 | 52 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +2.4% |
| Dividend StreakConsecutive years of raises | 6 | 25 |
| Dividend / ShareAnnual DPS | $6.06 | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.0% | +1.7% |
UNH leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CI leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
CI vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CI or UNH a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus 11. 3% for Cigna Corporation (CI). Cigna Corporation (CI) offers the better valuation at 12. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Cigna Corporation (CI) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CI or UNH?
On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.
4x versus UnitedHealth Group Incorporated at 27. 5x. On forward P/E, Cigna Corporation is actually cheaper at 9. 1x.
03Which is the better long-term investment — CI or UNH?
Over the past 5 years, Cigna Corporation (CI) delivered a total return of +16.
6%, compared to -2. 8% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +217. 0% versus CI's +124. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CI or UNH?
By beta (market sensitivity over 5 years), Cigna Corporation (CI) is the lower-risk stock at 0.
35β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 65% more volatile than CI relative to the S&P 500. On balance sheet safety, Cigna Corporation (CI) carries a lower debt/equity ratio of 75% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — CI or UNH?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus 11. 3% for Cigna Corporation (CI). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CI or UNH?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus 2. 2% for Cigna Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 3. 3% for CI. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CI or UNH more undervalued right now?
On forward earnings alone, Cigna Corporation (CI) trades at 9.
1x forward P/E versus 19. 9x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CI: 19. 0% to $328. 00.
08Which pays a better dividend — CI or UNH?
All stocks in this comparison pay dividends.
UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 4%, versus 2. 2% for Cigna Corporation (CI).
09Is CI or UNH better for a retirement portfolio?
For long-horizon retirement investors, Cigna Corporation (CI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
35), 2. 2% yield, +124. 1% 10Y return). Both have compounded well over 10 years (CI: +124. 1%, UNH: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CI and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CI is a mid-cap deep-value stock; UNH is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.